Supplementation
with Citicoline has been shown to promote memory, attention, and behavior in mentally healthy older adults as well.
Results: Patients treated
with citicoline plus an AChEI showed a statistically significant increase in MMSE between T0 and T1 (16.88 ± 3.38 versus 17.62 ± 3.64; p = 0.000) and between T1 and T2 (17.62 ± 3.64 versus 17.89 ± 3.54; p = 0.000).
Not exact matches
Objective: The aim of the present study was to show the effectiveness of oral
citicoline plus AChEIs in patients affected
with AD.
Citicoline assists the operation of brain cells, allows for maintenance of optimal memory function, and helps maintain cognitive ability
with age.